ArticleBritish journal of haematology2025

First-line tagraxofusp induces durable responses with prolonged survival in adults younger than 50 years with blastic plasmacytoid dendritic cell neoplasm: Post hoc analysis of a phase 2 trial.

Anthony S Stein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.